Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib effectively treats severe alopecia areata and is safe.

The higher dose supplement was more effective in treating female hair loss.

Excimer light therapy is more effective than low level laser therapy for treating alopecia areata.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

The AVET system effectively delivers genes to human keratinocytes and may help treat skin diseases.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

Vitexin Compound 1 may help reduce skin aging caused by UVA light.

A fast and accurate method was developed to measure alfuzosin and dutasteride in human plasma.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Tilapia skin matrix effectively aids skin wound healing and is a promising option for clinical use.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

New compounds show promise as nonsteroidal treatments for hair loss.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

A woman's sudden hair loss was linked to azathioprine use despite normal enzyme levels, and improved after stopping the drug and starting treatment.

Microagulhamento e intradermoterapia juntos melhoram o crescimento capilar em mulheres menopausadas.

Alopecia areata is the most common type of baldness treated with corticosteroids and minoxidil.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.